Age-stratified study on symptoms of upper airway obstruction and craniofacial development in children Authors: Hui Qu, Chang Liu, Jing Sun, Ying Zhai, Hangjin Li, Jizhe Wang Published: 2026 ABSTRACT ObjectiveTo investigate the association between symptoms of upper airway obstruction (UAO) and craniofacial development indicators in children aged 3–14 years, and to analyze specific differences among age groups.MethodsA total of 177 children presenting with UAO symptoms (e.g., nasal congestion, snoring, mouth breathing) were enrolled between April 2024 and April 2025. Participants were divided into three age groups: 3–6 years, 7–10 years, and 11–14 years. The OSA-18 questionnaire was completed by guardians to assess symptom severity. Cone-beam computed tomography (CBCT) was performed, and two-dimensional cephalometric analysis was conducted to measure 16 craniofacial parameters, including sagittal (∠SNA, ∠SNB, ∠ANB, ∠SNPog, ∠NP-FH), vertical (∠MP-SN, ∠FH-MP, Y-axis, anterior facial height, posterior facial height), dental (∠U1-SN, ∠U1-NA, ∠U1-L1, ∠L1-NB, ∠L1-MP), and mandibular body length parameters. Correlation analyses were conducted using Pearson’s or Spearman’s methods in SPSS 22.0.Results3–6-year group: Mouth breathing scores correlated positively with ∠MP-SN, ∠FH-MP, Y-axis angle, anterior facial height, and posterior facial height (r = 0.296, 0.366, 0.233, 0.351, 0.278; P = 0.011, 0.001, 0.046, 0.002, 0.016). All UAO symptoms correlated positively with anterior facial height.7–10-year group: Symptom duration correlated positively with ∠SNA and ∠U1-L1 (r = 0.256, 0.228; P = 0.021, 0.041) but negatively with ∠U1-SN (r = -0.278, P = 0.012). Apnea scores correlated negatively with ∠NP-FH (r = -0.257, P = 0.020). Choking/gasping scores correlated negatively with ∠SNB (r = -0.238, P = 0.033), while total OSA-18 scores correlated positively with ∠ANB (r = 0.246, P = 0.027).11–14-year group: Apnea scores correlated positively with ∠L1-NB (r = 0.464, P = 0.030).ConclusionUAO symptoms are correlated with altered craniofacial developmental parameters in children, with notable age-related differences. The period from 3 to 10 years may constitute a critical window of susceptibility to these UAO-associated craniofacial changes. Consistent with existing literature, tonsillar hypertrophy is the most likely primary etiology of UAO in children aged 3–6 years, while adenoid hypertrophy may predominate in those aged 7–10 years. The patterns of craniofacial parameters correlated with UAO symptoms vary distinctly across these age groups. Individualized assessment and intervention strategies tailored to age-specific symptom profiles are essential to enable early identification and targeted management of high-risk children.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12903-026-08934-y. Introduction Upper airway obstruction (UAO) encompasses a spectrum of disorders characterized by structural or functional narrowing of the upper airway, which impairs normal respiratory function. Common symptoms include dyspnea, snoring, apnea, gasping/choking, and mouth breathing [1]. In children, UAO-related conditions often lead to sleep-disordered breathing (SDB) ; the prevalence of obstructive sleep apnea (OSA) diagnosed by polysomnography is estimated at 1–5% in children, varying with age and diagnostic thresholds [2, 3]. However, the prevalence of habitual snoring or symptomatic sleep-disordered breathing is considerably higher, highlighting a large population at potential risk for associated morbidities [3, 4]. Beyond this, UAO is strongly implicated in abnormal craniofacial development [1, 5, 6]. Furthermore, it has been associated, particularly in severe or untreated cases, with adverse neurocognitive outcomes [7]. Laurent M et al. [8]recently reported that children with attention-deficit/hyperactivity disorder (ADHD) exhibit a higher prevalence of obstructive sleep disorders and distinct cephalometric features, such as left mandibular deviation, likely due to maxillary constriction. The pathogenesis of pediatric UAO is closely linked to anatomical abnormalities and dynamic functional imbalances of the upper airway. Current evidence confirms that adenoid hypertrophy and tonsillar hyperplasia are the primary anatomical drivers: these structures occupy space in the nasopharynx and oropharynx, respectively, resulting in physical narrowing of the airway [1, 9, 10]. Other contributing factors include congenital craniofacial anomalies (e.g., mandibular retrusion, high palatal vault), acute or chronic mucosal inflammation with consequent edema, and obesity-related peripharyngeal fat deposition—all of which may lead to UAO through distinct mechanisms [9, 11]. Although existing studies have confirmed an association between pediatric UAO and craniofacial development, research has predominantly focused on relationships between isolated anatomical factors (e.g. adenoids or tonsils) and specific craniofacial characteristics, without systematic age stratification. Furthermore, childhood represents a critical window for the synchronous development of craniofacial structures and the upper airway; however, the dynamic interplay between UAO and craniofacial growth patterns across different developmental stages has not been fully elucidated. This limitation has direct clinical consequences, as interventions targeting a single obstructive site often fail to fully correct abnormal craniofacial development, potentially resulting in recurrence of UAO symptoms. The study aims to analyze the correlation between symptoms of UAO (e.g. snoring, apnea, mouth breathing and all) and craniofacial development indicators in children across different age groups. The objective is to provide a theoretical foundation for developing personalized diagnosis and treatment strategies for children presenting with UAO symptoms. Materials and methods Study population This study was conducted in the Department of Otolaryngology at the Second Affiliated Hospital of Dalian Medical University. We enrolled consecutive patients who presented to our department between April 2024 and April 2025 with clinical symptoms of Upper Airway Obstruction (UAO), including snoring, mouth breathing, and nasal congestion. Notably, a subset of these children was referred by orthodontic departments for mandatory pre-treatment airway assessment due to craniofacial developmental concerns. A total of 177 children aged 3–14 years were included and stratified into three age groups (3–6, 7–10, and 11–14 years). Inclusion Criteria were: Age between 3 and 14 years; presence of clinical symptoms of UAO (e.g., nasal congestion, snoring, mouth breathing); written informed consent obtained from guardians. Exclusion criteria were: Previous upper airway surgery (e.g. adenoidectomy, tonsillectomy, nasal surgery); orthodontic treatment; neurological disorders; nasopharyngeal tumors; asthma or acute exacerbation of allergic rhinitis. Methods The OSA-18 questionnaire was completed by guardians or long-term cohabitants to assess the severity of UAO symptoms, under the guidance of trained medical staff. CBCT scanning was performed in children presenting with clinical symptoms of UAO to address the study aims. This approach is consistent with methodologies used in prior pediatric research for detailed craniofacial and airway assessment [12, 13]. To minimize risk, all scans employed age- and size-adjusted low-dose protocols adhering to the ALARA principle. Clinical data collection Data collection was divided into two distinct phases: clinical history documentation and OSA-18 Questionnaire. Clinical history A trained clinician recorded the demographic data and clinical history. Symptom duration was defined as the total time (months/years) since the initial onset of UAO symptoms (e.g., snoring, mouth breathing). OSA-18 questionnaire The OSA-18 questionnaire consists of 5 domains and 18 items. Our analysis included both the total OSA-18 score and the scores of specific items (Items 1, 2, 3, and 5) assessing snoring, apnea, gasping/choking, and mouth breathing, respectively. Each item is scored on a 1–7 scale, yielding a total score ranging from 18 to 126, with higher scores indicating more severe symptoms. In this study, the OSA-18 total and item scores were not used as diagnostic tools for obstructive sleep apnea. Upper airway CBCT scanning All CBCT scans were acquired in strict adherence to clinical indications. The primary indication was comprehensive assessment of upper airway patency and craniofacial morphology in children with clinical manifestations of UAO (e.g., snoring, mouth breathing). Specifically, as part of the interdisciplinary clinical management protocol, CBCT was indicated for orthodontic referral patients to rule out anatomical airway obstructions (e.g., severe adenoid facies, maxillary constriction) prior to orthodontic treatment. For patients with suspected tonsillar or adenoid hypertrophy, CBCT was additionally used to quantify airway cross-sectional area and precisely locate the obstruction site. Upper airway scanning was performed using the HiRes3D-Max CBCT system (LargeV Instrument Co., Ltd.). The scanning parameters were adjusted based on age and body size (voltage range: 100 kV, current: 6 mA, voxel size: 0.3 mm, scan time: 15 s).The CBCT scans were acquired with a field of view (FOV) of 15 cm × 15 cm, encompassing the entire craniofacial region from the sella turcica to the menton, including the upper airway from the nasopharynx to the hypopharynx. Contraindications (e.g. unremoved metallic implants) were strictly screened prior to scanning. The operational procedure was as follows: ① Parameter settings: Voltage was adjusted according to the age and body size of the child. ② Positioning: Metallic objects (e.g. earrings, bracelets, removable dentures, hearing aids) were removed. The chin was placed on the chin rest, and the head was stabilized using a head clamp with the Frankfort plane (the line connecting the superior margin of the external auditory canal and the infraorbital rim) parallel to the ground. Laser alignment was used to calibrate the midline. ③ Breathing cooperation: The child was instructed to sit upright with the orbitomeatal plane parallel to the ground, teeth in maximal intercuspation, and to maintain normal breathing during scanning (swallowing or deep breathing was avoided to prevent motion artifacts). If severe motion artifacts were detected (Hounsfield unit deviation > 10%), the scan was repeated. Observation indicators Landmark identification and measurements were performed twice by the same well-trained otolaryngologist using SmartVPro at a 14-day interval. A total of 14 soft-tissue and hard-tissue landmarks and 4 reference planes were used in this study (see Tables 1 and 2, and Fig. 1). Table 1Landmarks and definitionsLandmarksNameDefinitionsSSellathe center of the sella turcicaNNasionthe deepest point in the concavity of the nasofrontal suturePoPorionthe most superior point of the bony external audi tory meatusAA pointthe deepest point in the concavity of the anterior maxilla between the anterior nasal spine and the alveolar crestU1upper central incisal tipupper central incisor cutting pointU1Aupper central root apexroot point of upper central incisorL1lower central incisal tipthe cutting point of the lower central incisorL1Alower central root apexroot point of lower central incisorBB pointthe deepest point in the concavity of the anterior mandible between the alveolar crest and pogonion.MeMentonthe most inferior point of the mandibular symphysisGnGnathionthe most anteroinferior point on the bony chinGoGonionthe most posterior-inferior point on the angle of the mandibleOrOrbitalethe most inferior point on the infraorbital marginPogpogonionthe most anterior point on the chin Table 1Landmarks and definitionsLandmarksNameDefinitionsSSellathe center of the sella turcicaNNasionthe deepest point in the concavity of the nasofrontal suturePoPorionthe most superior point of the bony external audi tory meatusAA pointthe deepest point in the concavity of the anterior maxilla between the anterior nasal spine and the alveolar crestU1upper central incisal tipupper central incisor cutting pointU1Aupper central root apexroot point of upper central incisorL1lower central incisal tipthe cutting point of the lower central incisorL1Alower central root apexroot point of lower central incisorBB pointthe deepest point in the concavity of the anterior mandible between the alveolar crest and pogonion.MeMentonthe most inferior point of the mandibular symphysisGnGnathionthe most anteroinferior point on the bony chinGoGonionthe most posterior-inferior point on the angle of the mandibleOrOrbitalethe most inferior point on the infraorbital marginPogpogonionthe most anterior point on the chin Landmarks and definitions Table 2Datum planes and definitionsPlanesNameDefinitionsFH planeFrankfort horizontal planethe line joining Po and OrSN planeAnterior cranial base planethe line joining S and NMP planeMandibular planethe line passing from Gonion to MentonNP planeN-Pog planethe line passing from nasion to pogonion Table 2Datum planes and definitionsPlanesNameDefinitionsFH planeFrankfort horizontal planethe line joining Po and OrSN planeAnterior cranial base planethe line joining S and NMP planeMandibular planethe line passing from Gonion to MentonNP planeN-Pog planethe line passing from nasion to pogonion Datum planes and definitions Fig. 1Cephalometric landmarks used in the customized analysis. a Landmarks : S-Sella, center of the Sella turcica; N-Nasion, the deepest point in the concavity of the nasofrontal suture; Po-Porion, the most superior point of the bony external auditory meatus; A-A point, the deepest point in the concavity of the anterior maxilla between the anterior nasal spine and the alveolar crest; U1-upper central incisal tip, upper central incisor cutting point; U1A-upper central root apex, root point of upper central incisor; L1-lower central incisal tip, the cutting point of the lower central incisor; L1A-lower central root apex, root point of lower central incisor; B-B point, the deepest point in the concavity of the anterior mandible between the alveolar crest and pogonion; Me-Menton, The most inferior point of the mandibular symphysis; Gn-Gnathion, the most anteroinferior point on the bony chin; Go-Gonion, the most posterior-inferior point on the angle of the mandible; Or-Orbitale, the most inferior point on the infraorbital margin; Pog-pogonion, Most anterior point on the chin. b Datum Planes: FH plane-Frankfort horizontal plane, the line joining Po and Or; SN plane-Anterior cranial base plane, the line joining S and N; MP plane-Mandibular plane, the line passing from Gonion to Menton; NP plane-N-Pog plane, the line passing from nasion to pogonion Cephalometric landmarks used in the customized analysis. a Landmarks : S-Sella, center of the Sella turcica; N-Nasion, the deepest point in the concavity of the nasofrontal suture; Po-Porion, the most superior point of the bony external auditory meatus; A-A point, the deepest point in the concavity of the anterior maxilla between the anterior nasal spine and the alveolar crest; U1-upper central incisal tip, upper central incisor cutting point; U1A-upper central root apex, root point of upper central incisor; L1-lower central incisal tip, the cutting point of the lower central incisor; L1A-lower central root apex, root point of lower central incisor; B-B point, the deepest point in the concavity of the anterior mandible between the alveolar crest and pogonion; Me-Menton, The most inferior point of the mandibular symphysis; Gn-Gnathion, the most anteroinferior point on the bony chin; Go-Gonion, the most posterior-inferior point on the angle of the mandible; Or-Orbitale, the most inferior point on the infraorbital margin; Pog-pogonion, Most anterior point on the chin. b Datum Planes: FH plane-Frankfort horizontal plane, the line joining Po and Or; SN plane-Anterior cranial base plane, the line joining S and N; MP plane-Mandibular plane, the line passing from Gonion to Menton; NP plane-N-Pog plane, the line passing from nasion to pogonion Cephalometric parameter (angles): SNA angle (SNA): inward angle toward the cranium between the NA line and the SN plane.SNB angle (SNB): inward angle toward the cranium between the NB line and the SN plane.ANB angle (ANB): angle between the NA and NB lines.SNPog angle (SNPog): angle between S, N, and Pog.NP-FH angle: angle formed by NP plane and FH plane.MP-SN angle: inward angle toward the cranium between MP plane and SN plane.MP-FH angle: angle formed by MP plane and FH plane.Y-Axis: inward angle toward the cranium between the S-Gn line and the SN plane.U1-SN angle: the anterior inferior angle between the long axis of the upper central incisor (U1-U1A line) and the SN plane.U1-NA angle: the inferior anterior angle between the long axis of the upper central incisor (U1-U1A line) and the NA line (line connecting Point N to Point A).U1-L1 angle: the angle between the long axis of the upper central incisor (U1-U1A line) and the extended line of the long axis of the lower central incisor (L1-L1A line).L1-NB angle: the inferior anterior angle between the long axis of the lower central incisor (L1-L1A line) and the NB line (line connecting Point N to Point B).L1-MP angle: the posterosuperior angle between the long axis of the lower central incisor (L1-L1A line) and the MP plane.Mandibular body length (Go-Gn): distance between gonion and gnathion.Anterior facial height (N-Me): distance between nasion and menton.Posterior facial height (S-Go): distance between sella and gonion. SNA angle (SNA): inward angle toward the cranium between the NA line and the SN plane. SNA angle (SNA): inward angle toward the cranium between the NA line and the SN plane. SNB angle (SNB): inward angle toward the cranium between the NB line and the SN plane. SNB angle (SNB): inward angle toward the cranium between the NB line and the SN plane. ANB angle (ANB): angle between the NA and NB lines. ANB angle (ANB): angle between the NA and NB lines. SNPog angle (SNPog): angle between S, N, and Pog. SNPog angle (SNPog): angle between S, N, and Pog. NP-FH angle: angle formed by NP plane and FH plane. NP-FH angle: angle formed by NP plane and FH plane. MP-SN angle: inward angle toward the cranium between MP plane and SN plane. MP-SN angle: inward angle toward the cranium between MP plane and SN plane. MP-FH angle: angle formed by MP plane and FH plane. MP-FH angle: angle formed by MP plane and FH plane. Y-Axis: inward angle toward the cranium between the S-Gn line and the SN plane. Y-Axis: inward angle toward the cranium between the S-Gn line and the SN plane. U1-SN angle: the anterior inferior angle between the long axis of the upper central incisor (U1-U1A line) and the SN plane. U1-SN angle: the anterior inferior angle between the long axis of the upper central incisor (U1-U1A line) and the SN plane. U1-NA angle: the inferior anterior angle between the long axis of the upper central incisor (U1-U1A line) and the NA line (line connecting Point N to Point A). U1-NA angle: the inferior anterior angle between the long axis of the upper central incisor (U1-U1A line) and the NA line (line connecting Point N to Point A). U1-L1 angle: the angle between the long axis of the upper central incisor (U1-U1A line) and the extended line of the long axis of the lower central incisor (L1-L1A line). U1-L1 angle: the angle between the long axis of the upper central incisor (U1-U1A line) and the extended line of the long axis of the lower central incisor (L1-L1A line). L1-NB angle: the inferior anterior angle between the long axis of the lower central incisor (L1-L1A line) and the NB line (line connecting Point N to Point B). L1-NB angle: the inferior anterior angle between the long axis of the lower central incisor (L1-L1A line) and the NB line (line connecting Point N to Point B). L1-MP angle: the posterosuperior angle between the long axis of the lower central incisor (L1-L1A line) and the MP plane. L1-MP angle: the posterosuperior angle between the long axis of the lower central incisor (L1-L1A line) and the MP plane. Mandibular body length (Go-Gn): distance between gonion and gnathion. Mandibular body length (Go-Gn): distance between gonion and gnathion. Anterior facial height (N-Me): distance between nasion and menton. Anterior facial height (N-Me): distance between nasion and menton. Posterior facial height (S-Go): distance between sella and gonion. Posterior facial height (S-Go): distance between sella and gonion. Reliability A reliability assessment was conducted to ensure robustness. The primary well-trained otolaryngologist performed measurements twice (14-day interval) to assess intra-rater reliability. A second experienced otolaryngologist independently measured a random subset of scans, blinded to the primary results, to assess inter-rater reliability. Intraclass correlation coefficients (ICCs) ranged from 0.85 to 0.95, indicating excellent agreement. Statistical analysis Statistical analyses were performed using SPSS software (version 22.0). As the distribution of OSA-18 symptom scores and craniofacial parameters may vary across developmental stages, normality was assessed separately for each variable within each age subgroup using the Shapiro-Wilk test. (Supplementary Table 1) Data with a normal distribution were analyzed using Pearson’s correlation coefficient. For data not conforming to a normal distribution, Spearman’s rank correlation coefficient was applied. The ICCs was used to assess inter- and intra-rater reliability for airway measurements. A P-value of less than 0.05 was considered statistically significant. Ethics This study was approved by the Ethics Committee of the Second Affiliated Hospital of Dalian Medical University (KY-2024-100-01-01) and conducted in accordance with the principles of the 1964 Declaration of Helsinki and its amendments. Prior to enrollment, written informed consent was obtained from all participants’ guardian. CBCT scans were performed exclusively when clinically indicated to minimize radiation exposure. Data were de-identified and stored securely in compliance with GDPR regulations. Results Baseline characteristics Group 3–6 years: 74 subjects (37 males, 37 females; mean age 4.49 ± 1.02 years). Group 7–10 years: 81 subjects (48 males, 33 females; mean age 8.22 ± 1.18 years). Group 11–14 years: 22 subjects (16 males, 6 females; mean age 12.59 ± 1.10 years). Correlation analysis between age and craniofacial development parameters As a continuous variable, age was significantly correlated with the majority of craniofacial parameters (11/16). In contrast, within each age-stratified subgroup, far fewer parameters remained significantly associated with age—five in the 3–6-year group, seven in the 7–10-year group, and merely two in the 11–14-year group—highlighting that age stratification effectively attenuated age-related confounding. Detailed results are presented in Table 3. Table 3Correlation analysis between age and craniofacial development parametersPredictorGroup 3–6 yearsGroup 7–10 yearsGroup 11–14 yearsALL∠SNA r 0.040.150-0.0970.066 P 0.7340.1830.6690.385∠SNB r 0.0220.308-0.4890.117 P 0.8500.005*0.021*0.120∠ANB r -0.063-0.2530.691-0.144 P 0.5910.023*0*0.057∠SNPog r 0.0740.375-0.4130.163 P 0.5320.001*0.0560.030*∠NP-FH r 0.0490.115-0.2290.161 P 0.9800.3070.3050.032*∠MP-SN r -0.112-0.2490.3590.029 P 0.3410.025*0.1010.704∠FH-MP r -0.065-0.1080.3590.035 P 0.5800.3370.1010.646Y-Axis r 0.109-0.0180.1550.154 P 0.3540.8730.4900.040*∠U1-SN r -0.235-0.2150.233-0.420 P 0.044*0.0540.2960*∠U1-NA r 0.1160.2220.1130.406 P 0.3240.047*0.9170*∠U1-L1 r 0.1830.1440.0770.440 P 0.1190.20.7340*∠L1-NB r -0.233-0.061-0.042-0.308 P 0.046*0.5860.8540*∠L1-MP r 0.2230.0750.0630.367 P 0.0560.5050.7790*Mandibular body length r 0.4320.288-0.2240.528 P 0*0.009*0.3170*Anterior facial height r 0.4750.195-0.0480.557 P 0*0.0820.8300*Posterior facial height r 0.2750.275-0.3230.529 P 0.013*0.013*0.1420** indicates P < 0.05, statistically significant Table 3Correlation analysis between age and craniofacial development parametersPredictorGroup 3–6 yearsGroup 7–10 yearsGroup 11–14 yearsALL∠SNA r 0.040.150-0.0970.066 P 0.7340.1830.6690.385∠SNB r 0.0220.308-0.4890.117 P 0.8500.005*0.021*0.120∠ANB r -0.063-0.2530.691-0.144 P 0.5910.023*0*0.057∠SNPog r 0.0740.375-0.4130.163 P 0.5320.001*0.0560.030*∠NP-FH r 0.0490.115-0.2290.161 P 0.9800.3070.3050.032*∠MP-SN r -0.112-0.2490.3590.029 P 0.3410.025*0.1010.704∠FH-MP r -0.065-0.1080.3590.035 P 0.5800.3370.1010.646Y-Axis r 0.109-0.0180.1550.154 P 0.3540.8730.4900.040*∠U1-SN r -0.235-0.2150.233-0.420 P 0.044*0.0540.2960*∠U1-NA r 0.1160.2220.1130.406 P 0.3240.047*0.9170*∠U1-L1 r 0.1830.1440.0770.440 P 0.1190.20.7340*∠L1-NB r -0.233-0.061-0.042-0.308 P 0.046*0.5860.8540*∠L1-MP r 0.2230.0750.0630.367 P 0.0560.5050.7790*Mandibular body length r 0.4320.288-0.2240.528 P 0*0.009*0.3170*Anterior facial height r 0.4750.195-0.0480.557 P 0*0.0820.8300*Posterior facial height r 0.2750.275-0.3230.529 P 0.013*0.013*0.1420** indicates P < 0.05, statistically significant Correlation analysis between age and craniofacial development parameters * indicates P < 0.05, statistically significant Correlation between UAO symptoms and craniofacial parameters by age group Correlations between the severity of UAO symptoms and craniofacial morphological parameters differed markedly across the three age groups. Results are stratified by vertical skeletal, sagittal skeletal, and dental parameters for each group as follows. 3–6 years UAO symptoms correlated predominantly with vertical facial dimensions and mandibular inclination, with no significant associations to sagittal skeletal parameters.Vertical parameters: All obstructive symptoms (snoring, apnea, gasping/choking, mouth breathing) were positively correlated with anterior facial height (N-Me) (snoring: r = 0.327, P = 0.004; apnea: r = 0.289, P = 0.012; gasping/choking: r = 0.277, P = 0.017; mouth breathing: r = 0.351, P = 0.002). Mouth breathing and snoring scores were positively correlated with ∠MP-SN (mouth breathing: r = 0.296, P = 0.011; snoring: r = 0.306, P = 0.008) , ∠FH-MP (mouth breathing: r = 0.366, P = 0.001; snoring: r = 0.292, P = 0.012) and Y-axis angle (mouth breathing: r = 0.233, P = 0.046; snoring: r = 0.322, P = 0.005) . Mouth breathing score was additionally positively correlated with posterior facial height (S-Go) (r = 0.278, P = 0.016).Sagittal parameters: No significant correlations were found between UAO symptoms and ∠SNA, ∠SNB or ∠ANB.Dental parameters: Symptom duration was negatively correlated with ∠U1-NA (r = -0.284, P = 0.014); no other dental angle showed a significant correlation with UAO symptoms. Vertical parameters: All obstructive symptoms (snoring, apnea, gasping/choking, mouth breathing) were positively correlated with anterior facial height (N-Me) (snoring: r = 0.327, P = 0.004; apnea: r = 0.289, P = 0.012; gasping/choking: r = 0.277, P = 0.017; mouth breathing: r = 0.351, P = 0.002). Mouth breathing and snoring scores were positively correlated with ∠MP-SN (mouth breathing: r = 0.296, P = 0.011; snoring: r = 0.306, P = 0.008) , ∠FH-MP (mouth breathing: r = 0.366, P = 0.001; snoring: r = 0.292, P = 0.012) and Y-axis angle (mouth breathing: r = 0.233, P = 0.046; snoring: r = 0.322, P = 0.005) . Mouth breathing score was additionally positively correlated with posterior facial height (S-Go) (r = 0.278, P = 0.016). Vertical parameters: All obstructive symptoms (snoring, apnea, gasping/choking, mouth breathing) were positively correlated with anterior facial height (N-Me) (snoring: r = 0.327, P = 0.004; apnea: r = 0.289, P = 0.012; gasping/choking: r = 0.277, P = 0.017; mouth breathing: r = 0.351, P = 0.002). Mouth breathing and snoring scores were positively correlated with ∠MP-SN (mouth breathing: r = 0.296, P = 0.011; snoring: r = 0.306, P = 0.008) , ∠FH-MP (mouth breathing: r = 0.366, P = 0.001; snoring: r = 0.292, P = 0.012) and Y-axis angle (mouth breathing: r = 0.233, P = 0.046; snoring: r = 0.322, P = 0.005) . Mouth breathing score was additionally positively correlated with posterior facial height (S-Go) (r = 0.278, P = 0.016). Sagittal parameters: No significant correlations were found between UAO symptoms and ∠SNA, ∠SNB or ∠ANB. Sagittal parameters: No significant correlations were found between UAO symptoms and ∠SNA, ∠SNB or ∠ANB. Dental parameters: Symptom duration was negatively correlated with ∠U1-NA (r = -0.284, P = 0.014); no other dental angle showed a significant correlation with UAO symptoms. Dental parameters: Symptom duration was negatively correlated with ∠U1-NA (r = -0.284, P = 0.014); no other dental angle showed a significant correlation with UAO symptoms. 7–10 years (mixed dentition stage) UAO symptoms were associated with sagittal skeletal discrepancies, with no significant correlations to vertical skeletal parameters.Vertical parameters: No significant associations were observed between UAO symptoms and anterior/posterior facial height or mandibular plane angles.Sagittal parameters: Total OSA-18 score was positively correlated with ∠ANB (r = 0.246, P = 0.027); gasping/choking score was negatively correlated with ∠SNB (r = -0.238, P = 0.033); symptom duration was positively correlated with ∠SNA (r = 0.256, P = 0.021); apnea score was negatively correlated with ∠NP-FH (r = -0.257, P = 0.020).Dental parameters: Symptom duration was negatively correlated with ∠U1-SN (r = -0.278, P = 0.012) and positively correlated with ∠U1-L1 (r = 0.228, P = 0.041). Vertical parameters: No significant associations were observed between UAO symptoms and anterior/posterior facial height or mandibular plane angles. Vertical parameters: No significant associations were observed between UAO symptoms and anterior/posterior facial height or mandibular plane angles. Sagittal parameters: Total OSA-18 score was positively correlated with ∠ANB (r = 0.246, P = 0.027); gasping/choking score was negatively correlated with ∠SNB (r = -0.238, P = 0.033); symptom duration was positively correlated with ∠SNA (r = 0.256, P = 0.021); apnea score was negatively correlated with ∠NP-FH (r = -0.257, P = 0.020). Sagittal parameters: Total OSA-18 score was positively correlated with ∠ANB (r = 0.246, P = 0.027); gasping/choking score was negatively correlated with ∠SNB (r = -0.238, P = 0.033); symptom duration was positively correlated with ∠SNA (r = 0.256, P = 0.021); apnea score was negatively correlated with ∠NP-FH (r = -0.257, P = 0.020). Dental parameters: Symptom duration was negatively correlated with ∠U1-SN (r = -0.278, P = 0.012) and positively correlated with ∠U1-L1 (r = 0.228, P = 0.041). Dental parameters: Symptom duration was negatively correlated with ∠U1-SN (r = -0.278, P = 0.012) and positively correlated with ∠U1-L1 (r = 0.228, P = 0.041). 11–14 years (adolescent stage) Few significant correlations were identified, with only apnea severity associated with a dental parameter; no sagittal or vertical skeletal parameters showed significant correlations with UAO symptoms.Vertical & sagittal parameters: No significant associations were found between UAO symptoms and any measured vertical or sagittal skeletal parameters.Dental parameters: Apnea score was positively correlated with ∠L1-NB (r = 0.464, P = 0.030); no other dental parameters showed significant correlations. Vertical & sagittal parameters: No significant associations were found between UAO symptoms and any measured vertical or sagittal skeletal parameters. Vertical & sagittal parameters: No significant associations were found between UAO symptoms and any measured vertical or sagittal skeletal parameters. Dental parameters: Apnea score was positively correlated with ∠L1-NB (r = 0.464, P = 0.030); no other dental parameters showed significant correlations. Dental parameters: Apnea score was positively correlated with ∠L1-NB (r = 0.464, P = 0.030); no other dental parameters showed significant correlations. Discussion The upper airway is a tubular cavity consisting of bony structures and soft tissues, with core functions including respiration, swallowing, air warming and humidification, and phonation [14]. During growth and development, genetic, environmental, and functional factors can narrow one or more segments of the upper airway, thereby inducing UAO. When upper airway function is impaired, children often adopt mouth breathing as an adaptive behavior. Alterations in airway temperature, humidity, and airflow turbulence may further disrupt craniofacial development [5], which may in turn exacerbate UAO, creating a vicious cycle [14–16]. Our analyses linked UAO symptom profiles (assessed via OSA-18) to age-specific craniofacial phenotypes, with weak (|r| = 0.2–0.3) and moderate (|r| = 0.3–0.46) correlations (Tables 3 and 4). This reflects craniofacial development has multiple factors— UAO and genetics, hormones, environmental factors [16, 17]. In children, subtle developmental deviations compound over the critical 3–10-year window. These patterns can help to decide which children need further sleep testing (e.g., polysomnography, the gold standard for definitive OSA diagnosis). Table 4Correlations between UAO symptom indicators and craniofacial development parameters by age groupsymptom Predictorsymptom durationSnoring scoreApnea scoreGasping/choking scoreMouth breathing scoreOSA-18 total scoreGroup 3–6 Years n = 74 ∠SNA r 0.015-0.1270.116-0.1000.0930.100 P 0.9000.2800.3240.3970.4300.396 ∠SNB r -0.018-0.088-0.048-0.0890.0020.055 P 0.8790.4560.6880.4500.9840.640 ∠ANB r -0.004-0.1170.159-0.0830.0550.045 P 0.9730.3220.1750.4830.6400.705 ∠SNPog r -0.107-0.134-0.038-0.103-0.0480.067 P 0.3650.2560.7510.3800.6860.571 ∠NP-FH r 0.0940.0070.0770.0880.0110.026 P 0.4270.9520.5120.4560.9260.827 ∠MP-SN r 0.1390.3060.3160.2630.2960.071 P 0.2370.008*0.006*0.024*0.011*0.549 ∠FH-MP r 0.1260.2920.3200.1750.3660.205 P 0.2840.012*0.005*0.1350.001*0.080 Y-Axis r 0.1030.3220.0530.0110.2330.203 P 0.3800.005*0.6550.9260.046*0.084 ∠UI-SN r 0.1090.0090.0850.0470.006-0.009 P 0.3550.9360.4740.6880.9630.936 ∠UI-NA r -0.284-0.0460.0400.052-0.0140.008 P 0.014*0.7000.7350.6580.9050.943 ∠UI-LI r -0.080-0.0270.2020.0950.1160.119 P 0.5010.8180.0840.4210.3240.314 ∠LI-NB r -0.0340.0410.010-0.0280.1230.080 P 0.7750.7300.9310.8130.2970.496 ∠LI-MP r 0.042-0.0030.2190.0830.1510.123 P 0.7220.9830.0610.4810.2000.295 Mandibular body length r 0.1390.1330.0250.1400.0130.077 P 0.2380.2600.8320.2330.9150.513 Anterior facial height r 0.2490.3270.2890.2770.3510.247 P 0.032*0.004*0.012*0.017*0.002*0.034* Posterior facial height r 0.1320.1960.1410.1690.2780.277 P 0.2620.0950.2300.1500.016*0.017*Group 7–10 Years n = 81 ∠SNA r 0.256-0.072-0.131-0.071-0.0480.017 P 0.021*0.5250.2430.5300.6730.882 ∠SNB r 0.141-0.071-0.218-0.238-0.056-0.142 P 0.2110.5280.050*0.033*0.6220.208 ∠ANB r 0.0760.0090.1010.1760.0330.246 P 0.5020.9360.3690.1160.7690.027* ∠SNPog r 0.118-0.048-0.182-0.173-0.086-0.117 P 0.2940.6670.1040.1230.4430.296 ∠NP-FH r 0.094-0.133-0.257-0.037-0.1870.008 P 0.4030.2370.020*0.7460.0940.945 ∠MP-SN r -0.142-0.0360.0070.0240.0800.039 P 0.2070.7520.9520.8300.4760.726 ∠FH-MP r -0.0630.0650.0510.0360.146-0.012 P 0.5740.5630.6500.7460.1920.917 Y-Axis r -0.0290.0820.1450.0270.182-0.020 P 0.7980.4680.1960.8120.1030.858 ∠UI-SN r -0.2780.0300.022-0.003-0.1220.091 P 0.012*0.7900.8440.9770.2780.419 ∠UI-NA r 0.188-0.0030.061-0.0270.055-0.041 P 0.0940.9810.5910.8070.6250.716 ∠UI-LI r 0.228-0.0100.048-0.0650.0680.005 P 0.041*0.9270.6700.5630.5450.968 ∠LI-NB r -0.0700.052-0.0630.0810.1130.046 P 0.5350.6470.5780.4710.3160.682 ∠LI-MP r 0.2050.0180.049-0.0980.0860.012 P 0.0660.8740.6630.3860.4470.915 Mandibular body length r -0.096-0.125-0.059-0.055-0.1220.045 P 0.3930.2650.5990.6270.2790.690 Anterior facial height r -0.0840.0240.103-0.014-0.0460.063 P 0.4570.8300.3620.8980.6850.574 Posterior facial height r 0.025-0.0180.107-0.024-0.0790.067 P 0.8260.8740.3420.8310.4850.551Group 11–14 Years n = 22 ∠SNA r 0.0980.3870.042-0.0060.1050.251 P 0.6630.0760.8520.9770.6420.259 ∠SNB r 0.0550.3800.021-0.028-0.0240.242 P 0.8070.0810.9250.9010.9140.278 ∠ANB r 0.071-0.0690.011-0.016-0.128-0.214 P 0.7540.7600.9620.9450.5690.339 ∠SNPog r 0.0540.3820.0860.0550.0060.202 P 0.8100.0800.7040.8070.9790.366 ∠NP-FH r 0.0500.2890.0500.1740.0060.027 P 0.8260.1920.8250.4390.9800.905 ∠MP-SN r -0.092-0.4060.048-0.0220.061-0.217 P 0.6850.0610.8330.9220.7870.331 ∠FH-MP r -0.119-0.383-0.019-0.1310.048-0.173 P 0.5990.0790.9330.5620.8320.441 Y-Axis r -0.175-0.376-0.076-0.201-0.105-0.066 P 0.4370.0840.7380.3700.6420.771 ∠UI-SN r -0.002-0.2900.1920.1180.1450.076 P 0.9930.1900.3920.6020.5200.736 ∠UI-NA r 0.1140.163-0.215-0.1190.1350.038 P 0.6150.4700.3380.5980.5480.867 ∠UI-LI r -0.0450.098-0.370-0.2150.145-0.204 P 0.8410.6640.0900.3370.5200.363 ∠LI-NB r 0.065-0.0620.4640.229-0.1210.201 P 0.7720.7850.030*0.3050.5920.369 ∠LI-MP r -0.175-0.018-0.418-0.3320.168-0.206 P 0.4350.9350.0530.1310.4540.357 Mandibular body length r -0.0530.204-0.0130.028-0.298-0.100 P 0.8150.3630.9540.9030.1770.659 Anterior facial height r -0.298-0.0910.1020.147-0.1420.175 P 0.1790.6870.6500.5140.5270.436 Posterior facial height r -0.1380.2130.2200.2710.0300.102 P 0.5400.3410.3240.2220.8930.650The correlation coefficients in this table are reported as Pearson's r or Spearman's ρ, depending on the normality test results of the specific variables within each respective age subgroup* indicates P < 0.05, statistically significant Table 4Correlations between UAO symptom indicators and craniofacial development parameters by age groupsymptom Predictorsymptom durationSnoring scoreApnea scoreGasping/choking scoreMouth breathing scoreOSA-18 total scoreGroup 3–6 Years n = 74 ∠SNA r 0.015-0.1270.116-0.1000.0930.100 P 0.9000.2800.3240.3970.4300.396 ∠SNB r -0.018-0.088-0.048-0.0890.0020.055 P 0.8790.4560.6880.4500.9840.640 ∠ANB r -0.004-0.1170.159-0.0830.0550.045 P 0.9730.3220.1750.4830.6400.705 ∠SNPog r -0.107-0.134-0.038-0.103-0.0480.067 P 0.3650.2560.7510.3800.6860.571 ∠NP-FH r 0.0940.0070.0770.0880.0110.026 P 0.4270.9520.5120.4560.9260.827 ∠MP-SN r 0.1390.3060.3160.2630.2960.071 P 0.2370.008*0.006*0.024*0.011*0.549 ∠FH-MP r 0.1260.2920.3200.1750.3660.205 P 0.2840.012*0.005*0.1350.001*0.080 Y-Axis r 0.1030.3220.0530.0110.2330.203 P 0.3800.005*0.6550.9260.046*0.084 ∠UI-SN r 0.1090.0090.0850.0470.006-0.009 P 0.3550.9360.4740.6880.9630.936 ∠UI-NA r -0.284-0.0460.0400.052-0.0140.008 P 0.014*0.7000.7350.6580.9050.943 ∠UI-LI r -0.080-0.0270.2020.0950.1160.119 P 0.5010.8180.0840.4210.3240.314 ∠LI-NB r -0.0340.0410.010-0.0280.1230.080 P 0.7750.7300.9310.8130.2970.496 ∠LI-MP r 0.042-0.0030.2190.0830.1510.123 P 0.7220.9830.0610.4810.2000.295 Mandibular body length r 0.1390.1330.0250.1400.0130.077 P 0.2380.2600.8320.2330.9150.513 Anterior facial height r 0.2490.3270.2890.2770.3510.247 P 0.032*0.004*0.012*0.017*0.002*0.034* Posterior facial height r 0.1320.1960.1410.1690.2780.277 P 0.2620.0950.2300.1500.016*0.017*Group 7–10 Years n = 81 ∠SNA r 0.256-0.072-0.131-0.071-0.0480.017 P 0.021*0.5250.2430.5300.6730.882 ∠SNB r 0.141-0.071-0.218-0.238-0.056-0.142 P 0.2110.5280.050*0.033*0.6220.208 ∠ANB r 0.0760.0090.1010.1760.0330.246 P 0.5020.9360.3690.1160.7690.027* ∠SNPog r 0.118-0.048-0.182-0.173-0.086-0.117 P 0.2940.6670.1040.1230.4430.296 ∠NP-FH r 0.094-0.133-0.257-0.037-0.1870.008 P 0.4030.2370.020*0.7460.0940.945 ∠MP-SN r -0.142-0.0360.0070.0240.0800.039 P 0.2070.7520.9520.8300.4760.726 ∠FH-MP r -0.0630.0650.0510.0360.146-0.012 P 0.5740.5630.6500.7460.1920.917 Y-Axis r -0.0290.0820.1450.0270.182-0.020 P 0.7980.4680.1960.8120.1030.858 ∠UI-SN r -0.2780.0300.022-0.003-0.1220.091 P 0.012*0.7900.8440.9770.2780.419 ∠UI-NA r 0.188-0.0030.061-0.0270.055-0.041 P 0.0940.9810.5910.8070.6250.716 ∠UI-LI r 0.228-0.0100.048-0.0650.0680.005 P 0.041*0.9270.6700.5630.5450.968 ∠LI-NB r -0.0700.052-0.0630.0810.1130.046 P 0.5350.6470.5780.4710.3160.682 ∠LI-MP r 0.2050.0180.049-0.0980.0860.012 P 0.0660.8740.6630.3860.4470.915 Mandibular body length r -0.096-0.125-0.059-0.055-0.1220.045 P 0.3930.2650.5990.6270.2790.690 Anterior facial height r -0.0840.0240.103-0.014-0.0460.063 P 0.4570.8300.3620.8980.6850.574 Posterior facial height r 0.025-0.0180.107-0.024-0.0790.067 P 0.8260.8740.3420.8310.4850.551Group 11–14 Years n = 22 ∠SNA r 0.0980.3870.042-0.0060.1050.251 P 0.6630.0760.8520.9770.6420.259 ∠SNB r 0.0550.3800.021-0.028-0.0240.242 P 0.8070.0810.9250.9010.9140.278 ∠ANB r 0.071-0.0690.011-0.016-0.128-0.214 P 0.7540.7600.9620.9450.5690.339 ∠SNPog r 0.0540.3820.0860.0550.0060.202 P 0.8100.0800.7040.8070.9790.366 ∠NP-FH r 0.0500.2890.0500.1740.0060.027 P 0.8260.1920.8250.4390.9800.905 ∠MP-SN r -0.092-0.4060.048-0.0220.061-0.217 P 0.6850.0610.8330.9220.7870.331 ∠FH-MP r -0.119-0.383-0.019-0.1310.048-0.173 P 0.5990.0790.9330.5620.8320.441 Y-Axis r -0.175-0.376-0.076-0.201-0.105-0.066 P 0.4370.0840.7380.3700.6420.771 ∠UI-SN r -0.002-0.2900.1920.1180.1450.076 P 0.9930.1900.3920.6020.5200.736 ∠UI-NA r 0.1140.163-0.215-0.1190.1350.038 P 0.6150.4700.3380.5980.5480.867 ∠UI-LI r -0.0450.098-0.370-0.2150.145-0.204 P 0.8410.6640.0900.3370.5200.363 ∠LI-NB r 0.065-0.0620.4640.229-0.1210.201 P 0.7720.7850.030*0.3050.5920.369 ∠LI-MP r -0.175-0.018-0.418-0.3320.168-0.206 P 0.4350.9350.0530.1310.4540.357 Mandibular body length r -0.0530.204-0.0130.028-0.298-0.100 P 0.8150.3630.9540.9030.1770.659 Anterior facial height r -0.298-0.0910.1020.147-0.1420.175 P 0.1790.6870.6500.5140.5270.436 Posterior facial height r -0.1380.2130.2200.2710.0300.102 P 0.5400.3410.3240.2220.8930.650The correlation coefficients in this table are reported as Pearson's r or Spearman's ρ, depending on the normality test results of the specific variables within each respective age subgroup* indicates P < 0.05, statistically significant Correlations between UAO symptom indicators and craniofacial development parameters by age group The correlation coefficients in this table are reported as Pearson's r or Spearman's ρ, depending on the normality test results of the specific variables within each respective age subgroup * indicates P < 0.05, statistically significant Children and adolescents aged 3–14 years experience rapid growth. Nasopharyngeal and oropharyngeal spaces expand with age: It is well-established that the palatine tonsils typically reach their peak size around 5 years of age, while adenoid tissue peaks later, between 7 and 10 years, before undergoing gradual involution [18, 19]. Consequently, the primary drivers of UAO differ substantially across developmental stages [20]. Kun et al. [4] studied 495 pediatric patients and found that UAO symptoms (e.g. snoring, apnea, mouth breathing and all) were associated with adenoid hypertrophy and obesity, with the influence of adenoid size diminishing after puberty. Their study was the first to examine the relationship between adenoid hypertrophy and obstructive sleep-related symptoms across distinct age groups. Similarly, Huang et al. [20] analyzed 942 children and further demonstrated that children with isolated adenoid hypertrophy exhibited unique craniofacial growth patterns in specific age ranges: vertical overgrowth was prominent in 9–12-year-olds, whereas 6–12-year-olds showed a longer mandibular body, a more anterior mandible, and a skeletal Class III horizontal pattern. Their work clarified the associations between adenoid hypertrophy and craniofacial development parameters across age groups. These findings emphasize that age stratification enables more precise analysis of relationships among upper airway structures (e.g. adenoids), obstructive symptoms, and craniofacial development. Results from the present study showed that when age was treated as a continuous variable, it correlated significantly with most craniofacial parameters (11/16). However, the number of parameters with significant age correlations decreased markedly (5/16, 7/16, and 2/16 in the three groups, respectively), after stratifying participants into age groups. This highlights the importance of age stratification in reducing the confounding effect of age. The results of this study demonstrated that in the 3–6-year-old group, the mouth-breathing score was positively correlated with ∠MP-SN, ∠FH-MP, ∠Y-axis, anterior facial height, and posterior facial height, indicating that more severe mouth-breathing symptoms were associated with increased backward and downward rotation of the mandible. Critically, this reflects a distinctive vertical, hyperdivergent growth pattern, characterized by increased anterior facial height and mandibular plane angle, consistent with the long-face phenotype. Notably, in the 3–6-year-old group, significant correlations were primarily with vertical facial dimensions and mandibular orientation, not with maxillomandibular positional angles such as SNA or SNB. This suggests that in early childhood, UAO impact is more sensitively captured by metrics of facial height and mandibular inclination, underscoring the importance of using developmentally appropriate cephalometric parameters. This is consistent with the craniofacial characteristics of children with OSA summarized by Flores et al. [21] based on a synthesis of nine articles. During mouth breathing, the tongue and mandible are positioned inferiorly [22], disrupting the muscular balance between the internal tongue and the external lips and cheeks, thereby forcing the mandible to rotate posteriorly and inferiorly [6, 17, 23, 24]. On the other hand, prolonged airflow impact in the oral cavity may promote convex facial profile development accompanied by steepening of the mandibular plane. In the 3–6-year-old group, the number of craniofacial development indicators influenced by snoring score, apnea score, and gasping/choking score decreased sequentially. Moreover, the correlated indicators largely overlapped with those associated with mouth breathing, which represents the core symptom and pathophysiological mechanism affecting craniofacial development in children aged 3–6 years. Additionally, it is noteworthy that all symptom scores were positively correlated with anterior facial height, indicating that more severe UAO symptoms are associated with greater anterior facial height and a stronger tendency toward long-face development. Dubey et al. [25] compared craniofacial characteristics of North Indian patients with obstructive sleep apnea (OSA) to those of healthy North Indian individuals and found that the anterior facial height (N-Me) was increased in the OSA group, which is consistent with our conclusions. This suggests that facial height is susceptible to UAO, and clinicians should pay attention to anterior facial height in children presenting with UAO symptoms and implement appropriate interventions. The duration of UAO symptoms was negatively correlated with ∠U1-NA, suggesting that prolonged UAO may lead to increased lingual inclination of the upper central incisors. In a cross-sectional study of Italian children aged 3–6 years, Paolantonio et al. [26] found that 15% and 7% of the children had reverse overjet (lingual inclination of upper incisors) and anterior crossbite, respectively, while 12% had open bite (labial inclination of upper incisors), which is generally consistent with our results. However, a systematic review and meta-analysis by Zhao et al. [16] showed that mouth-breathing children often exhibit labial inclination of the maxillary incisors, which contradicts our findings. This discrepancy may be because only a few of the studies included in that meta-analysis performed cephalometric analyses by age group, making age-based subgroup analysis unfeasible; thus, the results reflect craniofacial changes in mouth-breathing children aged 2–14 years overall. According to Lin et al. [17], when UAO is primarily caused by tonsillar hypertrophy, enlarged tonsils may inhibit normal maxillary development, leading to anterior crossbite, manifested as a decrease in ∠U1-NA. Given that palatine tonsil growth peaks at around 5 years of age [18], tonsillar hypertrophy is informed to be the main cause affecting craniofacial development in children aged 3–6 years presenting with UAO symptoms. In the 7–10-year-old group, the apnea score was negatively correlated with ∠NP-FH, indicating that more severe apnea symptoms were associated with a smaller ∠NP-FH, a flatter nasal plane, and impaired nasal development. The mechanism may be related to intermittent hypoxia induced by apneic events. Recurrent hypoxic states can disrupt the function of the hypothalamic–pituitary axis, inhibiting pulsatile secretion of growth hormone (GH) [27]. Given that GH plays a key regulatory role in the growth and development of the maxilla and nasal bones, its aberrant secretion may directly lead to delayed maxillary development and insufficient nasal structural growth, ultimately manifesting as a flattened nasal plane. The negative correlation between apnea scores and ∠NP − FH suggests that obstructive apnea (specifically, the repetitive upper airway obstruction and associated intermittent hypoxia) may impede normal maxillary development. This aligns with findings by Bruwier et al. [28], who demonstrated that adult OSA patients often present with reduced maxillary volume (hypomaxilla). Thus, the retrusion of upper incisors observed in our study may not only reflect dental adaptation but also indicate underlying skeletal hypomaxilla, a potential structural trait across age groups. The gasping/choking score was negatively correlated with ∠SNB, suggesting that more severe gasping/choking symptoms were associated with a smaller ∠SNB and more significant retrusion of the mandible relative to the cranial base, which is highly consistent with the characteristic “mandibular retrusion” observed in typical adenoid facies [20, 29]. The total OSA-18 score was positively correlated with ∠ANB, indicating that worsening UAO symptoms were associated with an increased ∠ANB, reflecting more pronounced maxillary protrusion and mandibular retrusion. The duration of UAO symptoms was positively correlated with ∠SNA and ∠U1-L1, and negatively correlated with ∠U1-SN. This suggests that prolonged UAO symptoms are associated with more significant maxillary protrusion (increased ∠SNA), increased anterior open bite (increased ∠U1-L1), and greater labial inclination of the upper incisors (decreased ∠U1-SN). The study by Zhan et al. [29] suggested that snoring lasting more than one year and mouth breathing lasting more than three months exacerbate dentofacial protrusion, which is generally consistent with our findings. Chronic UAO leads to compensatory mouth breathing in children, resulting in weakened elevator muscle function and overactive depressor muscles. This forces the mandible to rotate inferiorly and posteriorly, thereby causing abnormal jaw positional relationships and adaptive dental changes, ultimately leading to the development of a Class II malocclusion [16, 27]. In the 11–14-year-old group, the apnea score was positively correlated with ∠L1-NB, suggesting that more severe apnea symptoms were associated with greater labial inclination of the lower incisors. The study by Kang et al. [30] indicated that among white adolescents with Class I and Class II skeletal patterns,∠L1-NB is commonly used as a key indicator for evaluating orthodontic outcomes and serves as an important reference in personalized treatment planning. Therefore, an increased ∠L1-NB in children aged 11–14 may indicate the need for timely orthodontic intervention to correct compensatory dentoalveolar changes secondary to UAO, thereby preventing further progression of abnormal craniofacial development. No significant correlations were observed between other UAO-related indicators and craniofacial development parameters, suggesting that the critical period during which UAO symptoms are associated with craniofacial development is primarily between 3 and 10 years of age. Thus, early clinical intervention is recommended for children exhibiting UAO symptoms. In summary, UAO symptoms are associated with craniofacial development in children, with notable age-specific variations, particularly exerting a more pronounced influence in the 3–10-year age group. Therefore, individualized assessment and intervention strategies should be developed in clinical practice according to age: In children aged 3–6 years, mouth breathing has the greatest impact on craniofacial development, often leading to excessive vertical growth of the mandible or lingual inclination of the upper central incisors. Based on these findings, systematic evaluation for the mandible vertical development is essential in clinical management for this age group. The detection of a craniofacial abnormality should trigger a comprehensive upper airway evaluation to locate the primary site of obstruction. For instance, in a 3–6-year-old child presenting with a long-face phenotype, tonsillar hypertrophy is a likely key contributor. In such cases, tonsillectomy may be considered, but only after a full clinical assessment. In the 7–10-year age group, snoring and mouth breathing have limited effects, whereas apnea, gasping/choking, and UAO can drive the development of a typical adenoid facies phenotype, characterized by maxillary protrusion, mandibular retrusion, and Class II malocclusion. Prolonged symptom duration exacerbates maxillary protrusion and dental occlusal abnormalities. Thus, clinical assessment of children in this age group should focus on evaluating the frequency and severity of apnea and gasping/choking symptoms, with careful observation for classic signs of adenoid facies. Significant craniofacial abnormalities (particularly dentofacial protrusion) often indicate prolonged obstruction, necessitating prompt evaluation and consideration of surgical intervention to prevent further progression. For children aged 11–14 years, special attention should be paid to the history of apnea. Combined with occlusal relationship examination, orthodontic treatment should be initiated in a timely manner to correct compensatory dentoalveolar and skeletal deformities. These age-specific phenotypes correspond to distinct OSA subtypes [31]. The long-face pattern in 3–6-year-olds often points to tonsillar hypertrophy, whereas the adenoid facies in 7–10-year-olds typically indicates adenoid-dominant obstruction. This supports targeted interventions—such as tonsillectomy or adenoidectomy—tailored to the specific phenotype, moving beyond a uniform approach. This study innovatively integrates low-dose cone-beam computed tomography (CBCT) and the OSA-18 quality of life questionnaire for pediatric sleep-related breathing disorders to systematically analyze the relationship between the severity of UAO symptoms and overall anatomical structural abnormalities of the upper airway and craniofacial morphology. The OSA-18 questionnaire is straightforward to administer and is a well-established instrument widely used for assessing UAO symptoms [23, 32–34]. Unlike traditional 2D imaging [35], CBCT allows for multi-planar reconstruction, enabling precise three-dimensional cephalometric analysis of hard and soft tissue landmarks without the distortion or superimposition found in lateral cephalograms. This provided the measurement accuracy necessary for our correlational analysis, while delivering lower radiation doses than conventional CT. CBCT is thus a valuable tool extensively applied in dentistry and otorhinolaryngology [13, 36–38].Using refined age stratification, this study aims to establish a triple assessment framework—“site of obstruction, craniofacial phenotype, growth and development stage”—which not only provides a novel theoretical perspective for understanding the age-specific associations between UAO symptoms and craniofacial development but also offers evidence-based support for the early identification of high-risk pediatric patients requiring surgical intervention. Ultimately, this work is expected to lay the foundation for optimizing individualized treatment strategies for children with UAO symptoms. This study has several limitations. First, it focuses solely on the correlation between UAO symptoms and craniofacial development, without incorporating potential etiological variables such as hormonal levels or genetic factors. Second, the sample size was limited—only 22 subjects were included in the 11–14-year-old group—and age stratification was not sufficiently refined to fully eliminate the influence of age on upper airway anatomy. Furthermore, we did not systematically analyze the role of obesity. Kohler et al. [39] demonstrated stronger associations between obesity and OSA in adolescents compared to young children. Our future research could integrate this variable to clarify its age-specific interaction with UAO and craniofacial development. Moreover, CBCT provides static anatomical images obtained during wakefulness and does not capture the dynamic physiological changes in the upper airway during sleep. Therefore, our correlations reflect associations with structural anatomy rather than real-time obstructive events. Furthermore, while our study focused on two‑dimensional cephalometric parameters, three‑dimensional volumetric analysis of maxillomandibular structures—adjusted for body height—may yield additional insights into the craniofacial impacts of pediatric upper airway obstruction. Future studies combining polysomnography would help link these structural findings to functional sleep outcomes. Future studies should expand the sample size, adopt more detailed age stratification, and incorporate multidimensional influencing factors to more systematically elucidate the dynamic relationship between UAO and craniofacial development in children. Conclusion UAO symptoms are correlated with altered craniofacial developmental parameters in children, with notable age-related differences. The period from 3 to 10 years may constitute a critical window of susceptibility to these UAO-associated craniofacial changes. These weak-to-moderate correlations, though statistically modest, identify age-specific craniofacial markers. Consistent with existing literature, tonsillar hypertrophy is the most likely primary etiology of UAO in children aged 3–6 years, while adenoid hypertrophy may predominate in those aged 7–10 years. The patterns of craniofacial parameters correlated with UAO symptoms vary distinctly across these age groups. Therefore, our findings support a phenotype-driven clinical approach. Recognizing these age-stratified craniofacial profiles can aid in early identification, guide targeted diagnostic evaluation (e.g., Naso endoscopy, sleep study), and inform personalized treatment planning that addresses the specific anatomical and functional contributors in each child. Supplementary Information Supplementary Material 1. Supplementary Material 1.